| Dr Tariq Ziad Haddadin, MD | |
|
701 N State Of Franklin Rd Ste 2, Johnson City, TN 37604-3645 | |
| (423) 926-4468 | |
| (423) 928-4838 |
| Full Name | Dr Tariq Ziad Haddadin |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 28 Years |
| Location | 701 N State Of Franklin Rd Ste 2, Johnson City, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003880295 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD39717 (Tennessee) | Secondary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | MD39717 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johnson City Medical Center | Johnson city, TN | Hospital |
| Franklin Woods Community Hospital | Johnson city, TN | Hospital |
| Sycamore Shoals Hospital | Elizabethton, TN | Hospital |
| Greeneville Community Hospital | Greeneville, TN | Hospital |
| Unicoi County Hospital | Erwin, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Karing Hearts Cardiology Pc | 9436567252 | 12 |
News Archive
NOXXON Pharma AG, a company focused on the development of mirror image oligonucleotide therapeutics called Spiegelmers®, announced today the successful closing of a €33 million Series D round of financing. The round was led by new investor, NGN Capital, and joined by existing investors TVM Capital, Sofinnova Partners, Edmond de Rothschild Investment Partners, Seventure Partners, VC Fonds Technologie Berlin GmbH, Dow Venture Capital, FCP OP MEDICAL BioHealth-Trends, IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, the Dieckell Group, and others.
A possible 'first-line' treatment for a rare bone loss disease has been identified by a research team led by Tohoku University in Japan. The research findings, published in the journal Molecular Cell, could also provide insight into treating age-related osteoporosis.
Ahead of the 2018 conference and expo, Pittcon has released an eBook that highlights the latest advances in a range of scientific disciplines. It is an ‘ultimate compilation' of scientific articles and interviews with some of the worlds leading scientists.
Exemestane, an aromatase inhibitor that blocks production of estrogen, may provide another post-surgery option for postmenopausal women with hormone-receptor positive, early-stage breast cancer.
Prion proteins are known to cause scrapie – a neurodegenerative condition. It is capable of debilitating damage to the nervous system. Researchers have successfully devised a treatment for this condition which prolonged the lives of the lab mice infected with the prions.
› Verified 7 days ago
| Entity Name | Karing Hearts Cardiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841895935 PECOS PAC ID: 9436567252 Enrollment ID: O20210415002935 |
News Archive
NOXXON Pharma AG, a company focused on the development of mirror image oligonucleotide therapeutics called Spiegelmers®, announced today the successful closing of a €33 million Series D round of financing. The round was led by new investor, NGN Capital, and joined by existing investors TVM Capital, Sofinnova Partners, Edmond de Rothschild Investment Partners, Seventure Partners, VC Fonds Technologie Berlin GmbH, Dow Venture Capital, FCP OP MEDICAL BioHealth-Trends, IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, the Dieckell Group, and others.
A possible 'first-line' treatment for a rare bone loss disease has been identified by a research team led by Tohoku University in Japan. The research findings, published in the journal Molecular Cell, could also provide insight into treating age-related osteoporosis.
Ahead of the 2018 conference and expo, Pittcon has released an eBook that highlights the latest advances in a range of scientific disciplines. It is an ‘ultimate compilation' of scientific articles and interviews with some of the worlds leading scientists.
Exemestane, an aromatase inhibitor that blocks production of estrogen, may provide another post-surgery option for postmenopausal women with hormone-receptor positive, early-stage breast cancer.
Prion proteins are known to cause scrapie – a neurodegenerative condition. It is capable of debilitating damage to the nervous system. Researchers have successfully devised a treatment for this condition which prolonged the lives of the lab mice infected with the prions.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tariq Ziad Haddadin, MD Po Box 5159, Johnson City, TN 37602-5159 Ph: (423) 926-4468 | Dr Tariq Ziad Haddadin, MD 701 N State Of Franklin Rd Ste 2, Johnson City, TN 37604-3645 Ph: (423) 926-4468 |
News Archive
NOXXON Pharma AG, a company focused on the development of mirror image oligonucleotide therapeutics called Spiegelmers®, announced today the successful closing of a €33 million Series D round of financing. The round was led by new investor, NGN Capital, and joined by existing investors TVM Capital, Sofinnova Partners, Edmond de Rothschild Investment Partners, Seventure Partners, VC Fonds Technologie Berlin GmbH, Dow Venture Capital, FCP OP MEDICAL BioHealth-Trends, IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, the Dieckell Group, and others.
A possible 'first-line' treatment for a rare bone loss disease has been identified by a research team led by Tohoku University in Japan. The research findings, published in the journal Molecular Cell, could also provide insight into treating age-related osteoporosis.
Ahead of the 2018 conference and expo, Pittcon has released an eBook that highlights the latest advances in a range of scientific disciplines. It is an ‘ultimate compilation' of scientific articles and interviews with some of the worlds leading scientists.
Exemestane, an aromatase inhibitor that blocks production of estrogen, may provide another post-surgery option for postmenopausal women with hormone-receptor positive, early-stage breast cancer.
Prion proteins are known to cause scrapie – a neurodegenerative condition. It is capable of debilitating damage to the nervous system. Researchers have successfully devised a treatment for this condition which prolonged the lives of the lab mice infected with the prions.
› Verified 7 days ago
Dr. Alan Cox, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2603 Avondale Dr, Johnson City, TN 37604 Phone: 423-767-8268 | |
Dr. Sheeba Anand, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 325 N State Of Franklin, Johnson City, TN 37614 Phone: 423-439-6283 | |
Dr. Charles Famoyin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 302 Wesley St, Suite 3, Johnson City, TN 37601 Phone: 423-282-0561 Fax: 423-268-2674 | |
Robert Taylor Means Jr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 325 N State Of Franklin Rd, 2nd Floor, Johnson City, TN 37604 Phone: 423-439-7280 Fax: 423-439-7314 | |
Dr. E Paul Getaz, MD, PHD, MFA, MBA Internal Medicine Medicare: Medicare Enrolled Practice Location: 5 Saint Annes Ct, Johnson City, TN 37604 Phone: 423-946-0708 | |
Timothy O Mcbride, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 E Main St, Johnson City, TN 37601 Phone: 423-929-2584 Fax: 423-722-2060 |